共 108 条
[21]
Hanger HC(2015)Computerized clinical decision support improves warfarin management and decreases recurrent venous thromboembolism Clin Appl Thromb Hemost 21 197-203
[22]
Geddes JA(1994)Advances in statistical methodology for the evaluation of diagnostic and laboratory tests Stat Med 13 499-508
[23]
Wilkinson TJ(1995)Controlling the false discovery rate: a practical and powerful approach to multiple testing J R Stat Soc B Methodol 57 289-300
[24]
Lee M(2015)Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial Lancet 385 2077-2087
[25]
Baker AE(2016)Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis Thromb Haemost 116 879-890
[26]
Kuwashiro T(2016)Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomized trial Lancet Neurol 15 566-573
[27]
Yasaka M(2015)Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa Am J Emerg Med 33 1562-1566
[28]
Itabashi R(2006)Thromboembolic adverse events after use of recombinant human coagulation factor VIIa JAMA 295 293-298
[29]
Dowlatshahi D(2005)Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage Neurocrit Care 2 263-267
[30]
Butcher KS(2016)Risk of venous thromboembolism after receiving prothrombin complex concentrate for warfarin-associated intracranial hemorrhage J Emerg Med 50 1-6